Cargando…

Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review

Background: Diabetic peripheral neuropathy (DPN) is the most frequent chronic complication and is that which generates the highest disability and mortality in diabetes mellitus (DM). As it is currently the only microvascular complication of DM without a specific treatment, prevention is essential. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvajal-Moreno, Lidia, Coheña-Jiménez, Manuel, García-Ventura, Irene, Pabón-Carrasco, Manuel, Pérez-Belloso, Ana Juana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948704/
https://www.ncbi.nlm.nih.gov/pubmed/35330052
http://dx.doi.org/10.3390/jcm11061723
_version_ 1784674717355999232
author Carvajal-Moreno, Lidia
Coheña-Jiménez, Manuel
García-Ventura, Irene
Pabón-Carrasco, Manuel
Pérez-Belloso, Ana Juana
author_facet Carvajal-Moreno, Lidia
Coheña-Jiménez, Manuel
García-Ventura, Irene
Pabón-Carrasco, Manuel
Pérez-Belloso, Ana Juana
author_sort Carvajal-Moreno, Lidia
collection PubMed
description Background: Diabetic peripheral neuropathy (DPN) is the most frequent chronic complication and is that which generates the highest disability and mortality in diabetes mellitus (DM). As it is currently the only microvascular complication of DM without a specific treatment, prevention is essential. The aim of this study was to determine the most effective preventive strategy to avoid or delay the appearance and/or development of DPN in patients with DM. Methods: A systematic search was carried out in the main health science databases (PubMed, Scopus, CINAHL, PEDro and The Cochrane Library) from 1 January 2010 to 31 August 2020. The study selection was conducted by two independent reviewers and data extraction was performed by the author. The eligibility criteria included randomized clinical trials (RCTs) and cohort studies from RCTs. Results: Eleven studies were selected that included 23,595 participants with DM. The interventions evaluated were intensive or standard glycemic control, the use of drugs to achieve glycemic control, and the promotion of a healthy lifestyle and exercise. Intensive glucose control achieved a significant reduction in the development of DPN in TIDM patients, and lifestyle modifications and exercise achieved it moderately in TIIDM patients. Conclusions: The main preventive strategy for DPN is intensive glycemic control with a target HbA1c < 6% in patients with TIDM and standard control of 7.0–7.9 in patients with TIIDM, incorporating lifestyle modifications.
format Online
Article
Text
id pubmed-8948704
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89487042022-03-26 Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review Carvajal-Moreno, Lidia Coheña-Jiménez, Manuel García-Ventura, Irene Pabón-Carrasco, Manuel Pérez-Belloso, Ana Juana J Clin Med Systematic Review Background: Diabetic peripheral neuropathy (DPN) is the most frequent chronic complication and is that which generates the highest disability and mortality in diabetes mellitus (DM). As it is currently the only microvascular complication of DM without a specific treatment, prevention is essential. The aim of this study was to determine the most effective preventive strategy to avoid or delay the appearance and/or development of DPN in patients with DM. Methods: A systematic search was carried out in the main health science databases (PubMed, Scopus, CINAHL, PEDro and The Cochrane Library) from 1 January 2010 to 31 August 2020. The study selection was conducted by two independent reviewers and data extraction was performed by the author. The eligibility criteria included randomized clinical trials (RCTs) and cohort studies from RCTs. Results: Eleven studies were selected that included 23,595 participants with DM. The interventions evaluated were intensive or standard glycemic control, the use of drugs to achieve glycemic control, and the promotion of a healthy lifestyle and exercise. Intensive glucose control achieved a significant reduction in the development of DPN in TIDM patients, and lifestyle modifications and exercise achieved it moderately in TIIDM patients. Conclusions: The main preventive strategy for DPN is intensive glycemic control with a target HbA1c < 6% in patients with TIDM and standard control of 7.0–7.9 in patients with TIIDM, incorporating lifestyle modifications. MDPI 2022-03-21 /pmc/articles/PMC8948704/ /pubmed/35330052 http://dx.doi.org/10.3390/jcm11061723 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Carvajal-Moreno, Lidia
Coheña-Jiménez, Manuel
García-Ventura, Irene
Pabón-Carrasco, Manuel
Pérez-Belloso, Ana Juana
Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review
title Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review
title_full Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review
title_fullStr Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review
title_full_unstemmed Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review
title_short Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review
title_sort prevention of peripheral distal polyneuropathy in patients with diabetes: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948704/
https://www.ncbi.nlm.nih.gov/pubmed/35330052
http://dx.doi.org/10.3390/jcm11061723
work_keys_str_mv AT carvajalmorenolidia preventionofperipheraldistalpolyneuropathyinpatientswithdiabetesasystematicreview
AT cohenajimenezmanuel preventionofperipheraldistalpolyneuropathyinpatientswithdiabetesasystematicreview
AT garciaventurairene preventionofperipheraldistalpolyneuropathyinpatientswithdiabetesasystematicreview
AT paboncarrascomanuel preventionofperipheraldistalpolyneuropathyinpatientswithdiabetesasystematicreview
AT perezbellosoanajuana preventionofperipheraldistalpolyneuropathyinpatientswithdiabetesasystematicreview